Vigorous 360 Wellness
Has any government agency taken action against Vigorous 360 Wellness over GLP-1 drugs?
Vigorous 360 Wellness is named in 1 action in this index: Connecticut Attorney General, cease and desist letters (allegations, not findings), Dec 3, 2025. Of the FDA GLP-1 warning letters and openFDA recall reports in this index as of Nov 15, 2026, none is addressed to a firm under this name.
FDA records were matched by exact name only. A firm can appear in FDA records under a different legal name.
- Place the releases give
- Brookfield, CT
- Actions in this index
- 1
- Latest release
- Dec 3, 2025
Records
| Release | ||||
|---|---|---|---|---|
| Dec 3, 2025 | Connecticut Attorney General | Cease and desist letters (allegations, not findings) | Semaglutide, Tirzepatide | portal.ct.gov |
What each release says
- Connecticut Attorney General, Dec 3, 2025, “Attorney General Tong Announces New Developments in Crackdown on Bootleg GLP-1 Weight Loss Drugs”: “Companies receiving the letters include CT Weight Loss Shot, which operates CT Weight Loss Shot in Danbury and Vigorous 360 Wellness in Brookfield and Radiance Medspa in Avon.” These are allegations; the release does not report a finding or judgment on them.
Other firms named in the same releases are listed on the enforcement page.
This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.
Sources
Records last pulled Nov 15, 2026. Every entry links to the original public record.